TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MAXIPURE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MAXIPURE

ST13

US500000079420187

Classe

1, 5

Pedido

79420187

Registro

8258218

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

22

Atualização mais recente

19/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5

Data de depósito

17/10/2024

Data de registro

19/05/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

19/05/2026

Última transação

19/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

16

Localização do titular

DE

Examinador

GUZICK, LEAH A

Unidade examinadora

O90

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Evonik Operations GmbH

Representantes

Scott D. Woldow Smith, Gambrell & Russell, LLP

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical additives for use in the manufacture of pharmaceuticals; chemical excipients and chemical intermediates for use in the manufacture of pharmaceutical products; amino acids for industrial purposes; peptides substrates for industrial purposes; proteins for use in industry, proteins for the food industry; proteins for use in pharmaceutical and nutritional product manufacturing; saccharide preparations, used as an ingredient in the manufacture of pharmaceutical and nutritional products, other than for medical use; galactose for industrial pharmaceutical and nutritional purposes; mannose for industrial purposes; antioxidants for use in the manufacture of pharmaceuticals; lipids for use in industry, namely, used in the manufacture of cosmetics, beverages, food products and food supplements; chemical preparations for use in the food industry; chemical preparations for the manufacture of food supplements; chemical excipients and chemical intermediate products for use in the manufacture of foodstuffs, in particular food supplements; chemical additives for use in the manufacture of probiotic products; chemical additives for use in the manufacture of pharmaceuticals, foodstuffs and pharmaceutical products; probiotic bacterial formulations, other than for medical use and veterinary use; bacteria for use in food manufacture; bacterial preparations for the food industry; probiotic bacteria for the food industry; bacterial cultures for addition to food products; probiotic bacterial cultures for the food industry; milk ferments for the food industry; bacteria for use in the manufacture of food supplements, food, nutritional products, pharmaceutical products and cosmetics; bacteriological cultures mediums, other than for medical and veterinary use; bacterial products, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; chemical analysis diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria, other than for medical or veterinary purposes; catalysts, in particular biochemical catalysts; chemical substances for preserving foodstuffs; all the foregoing for use in connection with the manufacture of cosmetics, food products, and pharmaceutical products and none of the aforesaid products for use in the manufacture of insecticides, adjuvants, agricultural chemicals, forestry, horticulture, energy and well drilling.

Classe 5

Pharmaceutical and veterinary preparations for the treatment of nutritional conditions, bacteriological conditions, and probiotic conditions; bacterial preparations for medical and veterinary preparations; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, nucleic acid sequences and chemical reagents; veterinary preparations, namely, antioxidants; adjuvants for medical purposes; amino acids for medical and veterinary purposes; amino acid preparations for medical, veterinary and pharmaceutical purposes; synthetic peptides for pharmaceutical purposes for the treatment of nutritional conditions; cellulose esters, fats, and oils for medical and veterinary uses; salts, in particular potassium and sodium salts for medicinal purposes; steroids; biological preparations for the treatment of probiotic conditions for medical and veterinary purposes; ferments for pharmaceutical purposes; yeast for dietary and pharmaceutical purposes; starch for dietary and pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; bacterial and bacteriological preparations for medical or veterinary purposes; bacterial poisons; cultures of microorganisms for medical or veterinary use; nutritive substances for microorganisms for medical or veterinary purposes; bouillons for bacteriological cultures for medical purposes or veterinary purposes; biological tissue cultures for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue-regenerative preparations; probiotic supplements; probiotic bacterial formulations for veterinary use; probiotic bacterial formulations for medical use; probiotic preparations for dietary purposes; probiotic preparations for medical use to help maintain a natural flora in the digestive system; probiotic preparations for medicinal purposes to maintain a natural flora in the digestive system; dietetic foods and beverages adapted for medical and veterinary purposes; dietetic foods adapted for medical purposes; albuminous preparations for medical purposes, namely, albumin dietary supplements; candy, medicated; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; dietary supplements for human beings; dietary supplements for animals; dietary supplements; dietetic preparations adapted for medical use; capsules sold empty for pharmaceutical purposes; sugar, in particular rock sugar and dextrose for medical purposes; glucose for medical purposes; albuminous foodstuffs for medical purposes, namely, albumin supplements; protein dietary supplements; dietary fiber for treating constipation; mineral dietary supplements; chemical preparations, namely, preparations of trace elements for medical and veterinary use, namely, for nutritional diseases, illnesses, and conditions; vitamin preparations.

Publicações

Histórico de despachos e eventos da marca no USPTO.

22 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

19/05/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

19/05/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

31/03/2026

PUBO

PUBLISHED FOR OPPOSITION

31/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/03/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/03/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

05/03/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/03/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

05/03/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/03/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/01/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/01/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/01/2026

RFNT

REFUSAL PROCESSED BY IB

02/08/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/07/2025

RFRR

REFUSAL PROCESSED BY MPU

11/07/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

15/05/2025

CNRT

NON-FINAL ACTION WRITTEN

14/05/2025

DOCK

ASSIGNED TO EXAMINER

01/04/2025

MAFR

APPLICATION FILING RECEIPT MAILED

31/03/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

31/03/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

27/03/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MAXIPURE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.